ATNF — 180 Life Sciences Balance Sheet

0.000.00%

Last trade - 00:00

TechnologyHighly SpeculativeMicro CapNeutral

Annual balance sheet for 180 Life Sciences, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	10-K	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash
Cash and Short Term Investments	2.11	8.22	6.97	1.98	4.59
Net Total Receivables	0.799	0.695	0.621	0.45	0.041
Prepaid Expenses
Total Other Current Assets
Total Current Assets	4.01	11.2	8.93	3.64	5.14
Net Property, Plant And Equipment	0	—	—	—	—
Net Goodwill
Net Intangible Assets
Total Assets	55.5	62.7	19.7	5.26	12.8
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	21.5	19.7	5.66	5.06	3.5
Long Term Debt
Total Long Term Debt
Total Debt
Deferred Income Tax
Total Other Liabilities
Total Liabilities	25.2	23.4	8.31	5.39	3.51
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	30.3	39.3	11.3	-0.128	9.25
Total Liabilities & Shareholders' Equity	55.5	62.7	19.7	5.26	12.8
Total Common Shares Outstanding
Total Preferred Shares Outstanding